glutamic acid has been researched along with antazoline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Assumpció Boronat, M; DeGregorio-Rocasolano, N; García-Sevilla, JA; Gasull, T; Lerma, J; Olmos, G; Paz Regalado, M; Trullas, R; Villarroel, A | 1 |
Bockaert, J; Fagni, L; Lafon-Cazal, M; Milhaud, D | 1 |
2 other study(ies) available for glutamic acid and antazoline
Article | Year |
---|---|
Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.
Topics: Agmatine; Animals; Antazoline; Benzofurans; Cell Line; Cells, Cultured; Cerebellum; Dioxanes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Electrophysiology; Glutamic Acid; Humans; Idazoxan; Imidazoles; Neuroprotective Agents; Patch-Clamp Techniques; Potassium; Radioligand Assay; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Styrenes | 1999 |
Inhibition of voltage-gated Ca2+ channels by antazoline.
Topics: Animals; Antazoline; Brain; Calcium Channel Blockers; Calcium Channels; Calcium Channels, N-Type; Calcium Channels, P-Type; Cells, Cultured; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fetus; Glutamic Acid; Hypoxia, Brain; Membrane Potentials; Mice; Neurons; Neuroprotective Agents; Neurotoxins; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Synaptic Transmission | 2002 |